Table 2 Summary of clinical data from 106 consecutive patients
Characteristics | Overall (n = 106) |
|---|---|
Sex (male/female) | 69/37 |
Age (years), median (range) | 84 (80–93) |
KPS, median (range) | 70 (30–100) |
Controlled primary disease and no extracranial metastases | 25 (24%) |
RTOG-RPA class II/class III | 56/50 |
Ongoing systemic chemotherapy | 31 (29%) |
Time from primary diagnosis to initial SRS (months), median (range) | 11.3 (0–246) |
Cumulative TV on initial SRS (mL), median (range) | 3.9 (0.2–53.3) |
No. of intracranial lesions at initial SRS, median (range) | 2 (1–16) |
No. of patients treated with 2-session SRS | 15 (14%) |